Literature DB >> 18812673

Assessing culprit lesions and active complex lesions in patients with early acute myocardial infarction by multidetector computed tomography.

Wei-Chun Huang1, Ming-Ting Wu, Kuan-Rau Chiou, Guang-Yuan Mar, Shih-Hung Hsiao, Shih-Kai Lin, Tung-Cheng Yeh, Yi-Luan Huang, Hsiang-Chiang Hsiao, Doyal Lee, Chuen-Wang Chiou, Shoa-Lin Lin, Chun-Peng Liu.   

Abstract

BACKGROUND: Accurate, non-invasive characterization of culprit lesions in patients after acute myocardial infarction (AMI) remains challenging. In this prospective study, multidetector row computed tomography (MDCT) is used to assess culprit and active complex lesions in patients early after AMI. METHODS AND
RESULTS: We enrolled 103 patients with first non ST-elevation AMI who underwent 64-slices MDCT and conventional coronary angiography (CCAG). The definition of culprit lesion, stable non-culprit lesions and non-culprit active complex lesions was based on the findings of CCAG. The lesions were analyzed with MDCT data. In culprit lesions (n=103), luminal artery stenosis, remodeling index, plaque area and burden were significantly higher than non-culprit lesions (n=129). Multivariate discriminant analysis showed that MDCT density could discriminate culprit from non-culprit lesions. Receiver-operator characteristic curve analysis identified the optimal cutoff value of lesion density for discrimination between culprit and non-culprit lesion as 49.6 Hounsfield units (HU); this value was associated with a sensitivity, specificity and accuracy of 88.4%, 87.4%, and 87.9%, respectively. The MDCT in the stable non-culprit lesions (81.8+/-15.5 HU) was significantly higher than that in culprit lesions or non-culprit active complex lesions (33.2+/-13.8 and 48.3+/-15.7 HU, p<0.001).
CONCLUSIONS: MDCT can predict culprit lesions in patients early after AMI, and identify multiple complex lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18812673     DOI: 10.1253/circj.cj-08-0165

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

1.  Diagnostic accuracy of 64-slice computed tomography coronary angiography in a large population of patients without revascularisation: registry data in NSTEMI acute coronary syndrome and influence of gender and risk factors.

Authors:  E Maffei; C Martini; C Tedeschi; P Spagnolo; A Zuccarelli; T Arcadi; A Guaricci; S Seitun; A C Weustink; N R Mollet; F Cademartiri
Journal:  Radiol Med       Date:  2011-06-04       Impact factor: 3.469

2.  Body Mass Index and Outcome of Acute Myocardial Infarction - Is There an Obesity Paradox?

Authors:  Chin-Chang Cheng; Wei-Chun Huang; Kuan-Rau Chiou; Feng-Yu Kuo; Cheng-Hung Chiang; Jin-Shiou Yang; Ko-Long Lin; Shin-Hung Hsiao; Hwong-Ru Hwang; Guang-Yuan Mar; Shoa-Lin Lin; Chuen-Wang Chiou; Chun-Peng Liu
Journal:  Acta Cardiol Sin       Date:  2013-09       Impact factor: 2.672

3.  The Effect of Intensified Low Density Lipoprotein Cholesterol Reduction on Recurrent Myocardial Infarction and Cardiovascular Mortality.

Authors:  Wei-Chun Huang; Tzu-Wen Lin; Kuan-Rau Chiou; Chin-Chang Cheng; Feng-Yu Kuo; Cheng-Hung Chiang; Jin-Shiou Yang; Ko-Long Lin; Shin-Hung Hsiao; Tong-Chen Yeh; Guang-Yuan Mar; Hsiang-Chiang Hsiao; Shoa-Lin Lin; Chuen-Wang Chiou; Chun-Peng Liu
Journal:  Acta Cardiol Sin       Date:  2013-09       Impact factor: 2.672

Review 4.  Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome.

Authors:  Paweł Gąsior; Piotr Desperak; Karolina Gierlaszyńska; Michał Hawranek; Marek Gierlotka; Mariusz Gąsior; Lech Poloński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-06-17       Impact factor: 1.426

5.  Impact of hepatitis C virus infection on long-term mortality after acute myocardial infarction: a nationwide population-based, propensity-matched cohort study in Taiwan.

Authors:  Shu-Hung Kuo; Wang-Ting Hung; Pei-Ling Tang; Wei-Chun Huang; Jin-Shiou Yang; Hsiao-Chin Lin; Guang-Yuan Mar; Hong-Tai Chang; Chun-Peng Liu
Journal:  BMJ Open       Date:  2018-01-26       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.